Raymond James & Associates’s Sleep Number SNBR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-39,114
| Closed | -$1.19M | – | 3961 |
|
|
2023
Q1 | $1.19M | Buy |
39,114
+1,096
| +3% | +$35.8K | ﹤0.01% | 2351 |
|
|
2022
Q4 | $988K | Sell |
38,018
-2,118
| -5% | -$64.3K | ﹤0.01% | 2442 |
|
|
2022
Q3 | $1.36M | Sell |
40,136
-805
| -2% | -$32.3K | ﹤0.01% | 2211 |
|
|
2022
Q2 | $1.27M | Sell |
40,941
-2,566
| -6% | -$109K | ﹤0.01% | 2297 |
|
|
2022
Q1 | $2.21M | Buy |
43,507
+32,291
| +288% | +$2.19M | ﹤0.01% | 2057 |
|
|
2021
Q4 | $859K | Buy |
11,216
+1,208
| +12% | +$101K | ﹤0.01% | 2718 |
|
|
2021
Q3 | $936K | Buy |
10,008
+580
| +6% | +$57.6K | ﹤0.01% | 2622 |
|
|
2021
Q2 | $1.04M | Buy |
9,428
+762
| +9% | +$86.8K | ﹤0.01% | 2566 |
|
|
2021
Q1 | $1.24M | Buy |
8,666
+110
| +1% | +$13.2K | ﹤0.01% | 2352 |
|
|
2020
Q4 | $700K | Sell |
8,556
-1,122
| -12% | -$77.8K | ﹤0.01% | 2579 |
|
|
2020
Q3 | $473K | Buy |
9,678
+2,202
| +29% | +$104K | ﹤0.01% | 2671 |
|
|
2020
Q2 | $311K | Buy |
+7,476
| New | +$238K | ﹤0.01% | 2897 |
|
|
2020
Q1 | – | Sell |
-20,376
| Closed | -$1M | – | 3697 |
|
|
2019
Q4 | $1M | Buy |
20,376
+10,261
| +101% | +$488K | ﹤0.01% | 2263 |
|
|
2019
Q3 | $418K | Sell |
10,115
-54,700
| -84% | -$2.34M | ﹤0.01% | 2780 |
|
|
2019
Q2 | $2.62M | Buy |
64,815
+25,915
| +67% | +$1M | ﹤0.01% | 1637 |
|
|
2019
Q1 | $1.83M | Sell |
38,900
-126,619
| -76% | -$5.1M | ﹤0.01% | 1819 |
|
|
2018
Q4 | $5.25M | Buy |
165,519
+27,110
| +20% | +$962K | 0.01% | 1076 |
|
|
2018
Q3 | $5.09M | Buy |
138,409
+57,666
| +71% | +$1.87M | 0.01% | 1208 |
|
|
2018
Q2 | $2.34M | Buy |
80,743
+33,193
| +70% | +$1.01M | ﹤0.01% | 1659 |
|
|
2018
Q1 | $1.67M | Buy |
47,550
+40,341
| +560% | +$1.48M | ﹤0.01% | 1811 |
|
|
2017
Q4 | $271K | Buy |
7,209
+545
| +8% | +$18.6K | ﹤0.01% | 2892 |
|
|
2017
Q3 | $207K | Sell |
6,664
-2,171
| -25% | -$67.8K | ﹤0.01% | 3023 |
|
|
2017
Q2 | $314K | Sell |
8,835
-13,978
| -61% | -$418K | ﹤0.01% | 2692 |
|
|
2017
Q1 | $566K | Buy |
22,813
+7,659
| +51% | +$172K | ﹤0.01% | 2303 |
|
|
2016
Q4 | $343K | Buy |
15,154
+69
| +0.5% | +$1.49K | ﹤0.01% | 2558 |
|
|
2016
Q3 | $326K | Sell |
15,085
-1,265
| -8% | -$31.1K | ﹤0.01% | 2567 |
|
|
2016
Q2 | $350K | Sell |
16,350
-114,477
| -88% | -$2.5M | ﹤0.01% | 2319 |
|
|
2016
Q1 | $2.54M | Buy |
130,827
+20,341
| +18% | +$388K | 0.01% | 1145 |
|
|
2015
Q4 | $2.37M | Sell |
110,486
-1,107
| -1% | -$25.3K | 0.01% | 1177 |
|
|
2015
Q3 | $2.44M | Buy |
111,593
+90,594
| +431% | +$2.31M | 0.01% | 1115 |
|
|
2015
Q2 | $631K | Sell |
20,999
-5,755
| -22% | -$182K | ﹤0.01% | 1973 |
|
|
2015
Q1 | $922K | Sell |
26,754
-37,397
| -58% | -$1.16M | ﹤0.01% | 1702 |
|
|
2014
Q4 | $1.73M | Sell |
64,151
-4,045
| -6% | -$101K | 0.01% | 1243 |
|
|
2014
Q3 | $1.43M | Sell |
68,196
-4,851
| -7% | -$102K | 0.01% | 1285 |
|
|
2014
Q2 | $1.51M | Sell |
73,047
-4,111
| -5% | -$77.6K | 0.01% | 1251 |
|
|
2014
Q1 | $1.4M | Buy |
+77,158
| New | +$1.34M | 0.01% | 1229 |
|
Other funds holding SNBR
DGI
VLKIM
SCM
SIM
Raymond James & Associates's SNBR Position: Q2 2023 in Review
Raymond James & Associates sold out of Sleep Number (SNBR) in Q2 2023, closing a stake of 39,114 shares — an estimated $1.19M sold.
Raymond James & Associates first reported a position in SNBR in Q1 2014 and held it in 36 quarters. The position peaked at $5.25M in Q4 2018. 162 funds tracked by Wall St. Rank hold SNBR as of Q2 2023.
- Raymond James & Associates reported no remaining Sleep Number position as of Q2 2023 after selling out during the quarter.
- Raymond James & Associates sold 39,114 Sleep Number shares in Q2 2023, an estimated $1.19M.
- Raymond James & Associates first reported a position in Sleep Number in Q1 2014 and held it in 36 quarters.
- Raymond James & Associates's Sleep Number position peaked at $5.25M in Q4 2018.
- 162 funds tracked by Wall St. Rank held Sleep Number as of Q2 2023.
Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.